chartexchange

KRRO
Korro Bio, Inc. Common Stock
stockNASDAQ

At CloseOct 2, 2026 3:59:48 PM EDT
9.65USD-0.566%(-0.06)153,135
Pre-marketOct 2, 2026 9:29:30 AM EDT
9.80USD+0.927%(+0.09)
Loading…
Loading…
142.69M
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Previous Close
$9.71
Beta
2.69
52-Week High
$55.89 2025-10-16
52-Week Low
$5.20 2025-12-02
SMA 50
$11.93
SMA 200
$11.69
Avg. Vol 10D
161,596
Avg. Vol 30D
161,615
Avg. Vol 90D
181,014
Relative Vol
0.95
6.44M
1.5800%
911
Nov 11, 2026 (37d)
KRRO Profile

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.

KRRO Performance
PeriodPriceDateChangeBeta
1W9.512026-09-28+1.89%-3.304
1M12.242026-09-04-20.83%-1.583
3M14.062026-07-06-31.08%1.155
6M13.792026-04-06-29.73%1.533
1Y43.702025-10-06-77.83%2.688
2Y33.592024-10-04-71.15%—
KRRO Stock Summary

Korro Bio, Inc. Common Stock (NASDAQ:KRRO) stock price today is $9.69, and today's volume is 153,135. KRRO is down 0.206% today. The 30 day average volume is 161,615. KRRO market cap is $142.69M with 14.73M shares outstanding.